This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- The use of biomarkers in neuroendocrine tumours
- Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy
- Post-traumatic intrahepatic splenosis mimicking a neuroendocrine tumour
- Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)
- The SNM Practice Guideline for Somatostatin Receptor Scintigraphy 2.0
- Exendin-4-Based Radiopharmaceuticals for Glucagonlike Peptide-1 Receptor PET/CT and SPECT/CT
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
- Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience
- Tumor Receptor Imaging
- The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies
- Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours
- Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours
- Molecular Imaging as In Vivo Molecular Pathology for Gastroenteropancreatic Neuroendocrine Tumors: Implications for Follow-Up After Therapy
- Long-Term Efficacy of Radionuclide Therapy in Patients with Disseminated Neuroendocrine Tumors Uncontrolled by Conventional Therapy
- Receptor Imaging in Oncology by Means of Nuclear Medicine: Current Status
- An Intrapatient Comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-Octreotide for Diagnosis of Somatostatin Receptor-Expressing Tumors
- Somatostatin Receptor Scintigraphy in Liver Metastasis Detection from Gastroenteropancreatic Neuroendocrine Tumors
- 110mIn-DTPA-D-Phe1-Octreotide for Imaging of Neuroendocrine Tumors with PET
- Detection of Neuroendocrine Tumors: 99mTc-P829 Scintigraphy Compared with 111In-Pentetreotide Scintigraphy
- Imaging appearances of metastases from neuroendocrine tumours of the pancreas
- Advances in radionuclide imaging: radionuclide imaging as a guide to therapy
- The New Technology of Combined Transmission and Emission Tomography in Evaluation of Endocrine Neoplasms
- Peptide Receptor Imaging and Therapy